Innohep syringe (tinzaparin): Reviews and patient testimonials
Back to the list of medications
Medication indications
innohep Syringe 10,000 IU/ml
Prophylaxis of venous thromboembolism in adult patients undergoing surgery, particularly orthopaedic, general or oncological surgery.
Prophylaxis of venous thromboembolism in non-surgical adult patients immobilised due to acute medical illness including: acute heart failure, acute respiratory failure, severe infections, active cancer, as well as exacerbation of rheumatic diseases.
Prevention of clotting in extracorporeal circuits during haemodialysis and haemofiltration in adults.
innohep Syringe 20,000 IU/ml
Treatment of venous thrombosis and thromboembolic disease including deep vein thrombosis and pulmonary embolus in adults.
Extended treatment of venous thromboembolism and prevention of recurrences in adult patients with active cancer.
For some patients with pulmonary embolism (e.g. those with severe haemodynamic instability) alternative treatment, such as surgery or thrombolysis, may be indicated.
Route of administration: Injectable
Molecule: tinzaparin
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.